Esperante Ventures

Esperante Ventures is a corporate venture capital firm affiliated with a global life science group, boasting leadership with deep operational expertise in the development, manufacturing, and global marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests . Since its establishment in 2004, Esperante has strategically invested in pharmaceutical and diagnostic companies across the US, UK, continental Europe, and Israel . The firm focuses on initial investments of up to EUR 2,000,000 per venture in collaboration with other investors, aiming for exits through sales or liquidity events within a three-year timeframe .